Actionable news
0
All posts from Actionable news
Actionable news in SRNE: Sorrento Therapeutics, Inc.,

Notification of inability to timely file Form 10-Q or 10-QSB

BGCOLOR="WHITE">

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:

PART I REGISTRANT INFORMATION

Sorrento Therapeutics, Inc.

Full name of Registrant

N/A

Former Name if Applicable

6380 Judicial Drive

Address of Principal Executive Office ( Street and Number )

San Diego, CA 92121

City, State and Zip Code

PART II RULE 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)

PART III NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not...


More